Clinical Trial Update: Evaluation of a Treat and Extend Regimen of Intravitreal Aflibercept for Macular Edema Secondary to CRVO [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating a treat-and-extend regimen of intravitreal aflibercept for macular edema due to central retinal vein occlusion has completed w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Retinal Vein Occlusion

Drugs mentioned

• intravitreal aflibercept (aflibercept)

Snippet

Sponsor: Bayer | Conditions: Central Retinal Vein Occlusion | Phase 4 | Status: COMPLETED | Results posted: 2020-07-08